ADARx Pharmaceuticals
- Active openings
- 1
- US-based roles
- 1
- Remote-friendly
- 0
- Last updated
- 2026-07-31
What ADARx Pharmaceuticals is hiring for
Open positions
1 activeAbout ADARx Pharmaceuticals
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for the Treatment of HAE
ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments
Onvuzosiran Provides Deep and Sustained Reduction of Plasma Kallikrein Levels for the Treatment of HAE
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress
ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as Chief Financial Officer and Chief Business Officer
ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE